AvicoreTM is a novel and leading-edge anti-HIV drug-screening technique on the basis of HTS
technology that was independently developed and validated with our own skill. It has also
been a key technology of the development of AVI-CO-004. Application of this type of
technology will facilitate efficient and early screening and development of drugs for various
anti-RNA virus therapies. Our numerous published studies support the potential use of this
Our novel CPP(Cell Penetrating Peptide) molecules and techniques discovered and developed by Avixgen is much more efficient
than any other well-known CPPs including Tat for example and similar ones. Exploiting our novel CPP, the selection of various
Cargo proteins as for investigational drugs for various potential medical indications has been established and currently under development.